Latest News

Minimizing Antibody Size to Maximize Research Potential

An interview with Dr. Dave Fancy, discussing the use of secondary antibodies in neurobiology and the research applications of nanobodies.

Source link

Related posts

Congenica Earns Major Role in Supporting World’s First Routine National Genomic Medicine Service


Keto Diet For Cancer Treatment: Does It Work?


STAT Plus: Cel-Sci is publicly upbeat about its cancer drug. Privately it’s trying to sell stock


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy